
Dr Antonio Gallo
Disclosure details
Antonio Gallo has received grants and personal fees from Amgen, Sanofi and Regeneron, Mylan Viatris, MSD, Akcea Therapeutics, Amryt, Servier, Novartis and Ultragenyx.Head of the Lipid Clinic and Cardiovascular Prevention Unit and Associate Professor, Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France